Chiome Bioscience Inc. [4583.T]
TOKYO, Apr 01 (Pulse News Wire) – Chiome Bioscience Inc. (4583.T) reported the exercise status for its 23rd tranche warrants with price adjustment clauses for the month of March 2026.
A total of 1,761,300 shares were delivered during the month, representing 12.95% of the outstanding warrant pool. As of the end of February 2026, there were 107,738 warrants unexercised out of a total of 10,773,800 shares. By the end of March, this number decreased to 90,125.
During March, 17,613 warrants were exercised across several dates, with prices ranging from 93.9 to ¥100.30 per share. Notable exercise days included March 10, March 16, and March 24, where 4,209, 1,404, and 1,000 warrants were exercised respectively. Additionally, Chiome Bioscience adhered to the exercise limitations set forth by the Tokyo Stock Exchange's Listing Regulations Article 434 and the Securities Association’s Rules Governing Third-Party Allocation Exercises.
As of the end of March, the overall exercise rate was calculated at 2.59%.
🟢 Confidence: High AI-translated content.